Form 8-K - Current report:
SEC Accession No. 0001213900-18-007235
Filing Date
2018-06-05
Accepted
2018-06-05 11:50:15
Documents
3
Period of Report
2018-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k053118_wizepharma.htm 8-K 22674
2 EXCLUSIVE DISTRIBUTION AGREEMENT DATED MAY 31, 2018 f8k053118ex10-1_wizepharma.htm EX-10.1 314211
3 PRESS RELEASE DATED JUNE 5, 2018 f8k053118ex99-1_wizepharma.htm EX-99.1 8818
  Complete submission text file 0001213900-18-007235.txt   346994
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 18880433
SIC: 2834 Pharmaceutical Preparations